Targeted molecular therapy on the horizon for large b-cell lymphomas

RESEARCH DETAILS

Led by Dr. Ari Melnick from Weill Cornell Medical College in New York, researchers have identified a nontoxic small-molecule inhibitor that seems capable of killing human lymphoma cells.

Here's what we know: The oncogene known as BCL6 is generally associated with diffuse large B-cell lymphoma (DLBCL). In order for DLBCL cells to survive, they need BCL6. When this gene is prevented from functioning, DLBCL cells die.

Call

So researchers have gone looking for the right BCL6 inhibitor, and they may have found it in a compound known as 79-6, which has proven effective in killing the DLBCL cell lines.

The discovery leads researchers to believe that such small compounds, and their ability to inhibit the growth of lymphoma cells, may provide a new therapeutic route for the successful treatment of lymphomas.

PUBLICATION & SOURCES

These findings were published in the journal Cancer Cell.

By Ross Bonander

Source: Medical News Today

Call

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...